Vertebroplasty Needles Market Report 2025

This Vertebroplasty Needles market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The vertebroplasty needles market size has grown rapidly in recent years. It will grow from $1 billion in 2024 to $1.13 billion in 2025 at a compound annual growth rate (CAGR) of 13%. The growth in the historic period can be attributed to an aging population, advancements in minimally invasive techniques, raising awareness, increasing healthcare expenditure, the expansion of healthcare infrastructure, and government support and funding.

The vertebroplasty needles market size is expected to see rapid growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to an increasing incidence of osteoporosis, a growing preference for minimally invasive surgeries, expansion in emerging markets, an aging global population, rising healthcare spending, and increasing professional training. Major trends in the forecast period include technological integration, innovation in needle design, AI and machine learning, personalized medicine, telemedicine integration, robotics and automation, and sustainability initiatives.

An anticipated rise in spine injuries is expected to drive the growth of the vertebroplasty needles market. Spine injuries encompass damage or trauma to the spinal cord, vertebrae, or surrounding tissues, leading to pain, loss of mobility, or paralysis. Factors contributing to the increase in spine injuries include aging populations, greater participation in sports, and the prevalence of motor vehicle accidents. Vertebroplasty needles play a vital role in stabilizing spine injuries by precisely injecting bone cement into fractured vertebrae to alleviate pain and restore vertebral strength. For example, the Spinal Injuries Association reported in May 2024 that the UK saw around 4,400 new cases of spinal cord injury annually, equating to one person becoming paralyzed every two hours and resulting in an estimated total prevalence of 105,000 spinal cord injuries in 2024. Therefore, the rising incidence of spine injuries is fueling the vertebroplasty needles market.

Major companies in the vertebroplasty needles market are focusing on developing innovative technologies, such as regenerative biomaterials, to enhance the effectiveness of spinal treatments, improve patient outcomes, and reduce recovery times. Regenerative biomaterials are designed to aid in the repair and regeneration of damaged tissues by mimicking the natural extracellular matrix. For example, in November 2022, RevBio, a US-based clinical-stage medical device company, launched an experiment to test its regenerative biomaterial, Tetranite. Tetranite is an injectable bone adhesive with significant potential for vertebroplasty and similar procedures. This material can bond bone fragments together and fill voids, providing immediate stability during the healing process, which is crucial in vertebroplasty for stabilizing fractured vertebrae and promoting recovery.

In October 2022, Halma plc, a UK-based technology company, acquired IZI Medical Products LLC for $175.12 million. This acquisition aims to bolster Halma's portfolio in the healthcare sector, particularly in image-guided surgery, interventional oncology, and interventional neuro and spine procedures. By leveraging IZI's innovative technologies and extensive patent portfolio, Halma seeks to improve patient care and quality of life. IZI Medical Products LLC is a US-based manufacturer specializing in minimally invasive spine procedure solutions, including vertebroplasty needles.

Major companies operating in the vertebroplasty needles market are Medtronic plc, Becton Dickinson and Company, Stryker Corporation, DePuy Synthes Inc, Cook Medical LLC, Merit Medical Systems Inc., Globus Medical Inc., Argon Medical Devices Inc., Amplitude Surgical SAS, OptiMed GmbH, Tecres S.p.A, Zavation Medical Products LLC, Auxein Medical Pvt Ltd, Captiva Spine Inc., Laurane Medical LLC, Osseon Technologies, Adroit Manufacturing Co., BIOPSYBELL S.R.L., Surtech Medical Inc., TAEYEON Medical Co. Ltd., Teknimed S A S.

North America was the largest region in the vertebroplasty needles market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty needles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vertebroplasty needles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A vertebroplasty needle is a specialized medical instrument used in the minimally invasive surgical procedure known as vertebroplasty. This procedure is typically performed to treat compression fractures in the spine, often caused by osteoporosis or trauma. The needle is used to inject bone cement (usually a type of acrylic resin) directly into the fractured vertebra under imaging guidance, such as fluoroscopy or a computed tomography (CT) scan, to stabilize the bone and relieve pain. It is designed to be precise and minimally traumatic to surrounding tissues during the cement injection process.

The main types of vertebroplasty needles are 2.5x100, 2.5x130, 3.2x100, and 3.2x130. A 2.5x100 vertebroplasty needle refers to a specific type of medical instrument used in vertebroplasty procedures. It encompasses various product types, such as bone cement needles and aspiration needles, for different procedure types, including percutaneous vertebroplasty and kyphoplasty. These needles can be distributed through hospital pharmacies, private clinics, retail pharmacies, drug stores, and e-commerce platforms.

The vertebroplasty needles market research report is one of a series of new reports that provides vertebroplasty needles market statistics, including vertebroplasty needles industry global market size, regional shares, competitors with a vertebroplasty needles market share, detailed vertebroplasty needles market segments, market trends and opportunities, and any further data you may need to thrive in the vertebroplasty needles industry. This vertebroplasty needles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vertebroplasty needles market consists of sales of bone cement, cannulas and trocars, injection systems, accessories, and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.